The Society for Cardiovascular Angiography and Interventions (SCAI) has announced that Dr. James B. Hermiller, MD, MSCAI, has been appointed as President for the 2024-25 term. Dr. Hermiller is a highly respected interventional cardiologist with a wealth of experience in the field of cardiovascular medicine.
Dr. Hermiller currently serves as the Medical Director of Interventional Cardiology at The Care Group in Indianapolis, Indiana. He is also an Associate Clinical Professor of Medicine at Indiana University School of Medicine. Dr. Hermiller has been actively involved in SCAI for many years, serving on various committees and task forces.
In his new role as President of SCAI, Dr. Hermiller will lead the organization in its mission to promote excellence in invasive and interventional cardiovascular medicine. He will work closely with the Board of Trustees and other key stakeholders to advance the field of interventional cardiology through education, research, and advocacy.
Dr. Hermiller’s appointment as President of SCAI is a testament to his dedication and commitment to improving patient care and outcomes in the field of cardiovascular medicine. His leadership and expertise will undoubtedly have a positive impact on the organization and its members.
Under Dr. Hermiller’s guidance, SCAI will continue to be at the forefront of innovation and advancement in interventional cardiology. His vision for the organization includes expanding educational opportunities for members, fostering collaboration among healthcare professionals, and advocating for policies that support high-quality patient care.
As President of SCAI, Dr. Hermiller will be a strong advocate for the field of interventional cardiology and will work tirelessly to ensure that patients receive the best possible care. His leadership will undoubtedly leave a lasting impact on the organization and the field of cardiovascular medicine as a whole.
In conclusion, Dr. James B. Hermiller’s appointment as President of SCAI for the 2024-25 term is a significant milestone for the organization and the field of interventional cardiology. His leadership and expertise will help shape the future of cardiovascular medicine and improve patient outcomes for years to come.